Five birds, one stone: Neutralization of α-hemolysin and 4 bi-component leukocidins ofStaphylococcus aureuswith a single human monoclonal antibody

Induction of Virulence Gene Expression in Staphylococcus aureus by Pulmonary Surfactant

(2014) Kenichi Ishii et al.   INFECTION AND IMMUNITY

The Bicomponent Pore-Forming Leucocidins of Staphylococcus aureus

(2014) Francis Alonzo et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

Staphylococcal Bicomponent Pore-Forming Toxins: Targets for Prophylaxis and Immunotherapy

(2014) M. Aman et al.   Toxins

Assessment of an Anti-Alpha-Toxin Monoclonal Antibody for Prevention and Treatment of Staphylococcus aureus-Induced Pneumonia

(2013) L. Hua et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Oxacillin Alters the Toxin Expression Profile of Community-Associated Methicillin-Resistant Staphylococcus aureus

(2013) Justine K. Rudkin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Serologic Correlate of Protective Immunity Against Community-Onset Staphylococcus aureus Infection

(2013) Stephanie A. Fritz et al.   CLINICAL INFECTIOUS DISEASES

Mechanism of Action and In Vivo Efficacy of a Human-Derived Antibody against Staphylococcus aureus α-Hemolysin

(2013) Davide Foletti et al.   JOURNAL OF MOLECULAR BIOLOGY

High throughput solution-based measurement of antibody-antigen affinity and epitope binning

(2013) Patricia Estep et al.   mAbs

Addressing polyspecificity of antibodies selected from an in vitro yeast presentation system: a FACS-based, high-throughput selection and analytical tool

(2013) Y. Xu et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids

(2013) Ashley L. DuMont et al.   TRENDS IN MICROBIOLOGY

Vaccine review: “Staphyloccocus aureus vaccines: Problems and prospects”

(2013) Kathrin U. Jansen et al.   VACCINE

Staphylococcus aureus α-Toxin: Nearly a Century of Intrigue

(2013) Bryan Berube et al.   Toxins

Anti-bacterial monoclonal antibodies: Back to the future?

(2012) Martin B. Oleksiewicz et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Identification of Anti-Alpha Toxin Monoclonal Antibodies That Reduce the Severity of Staphylococcus aureus Dermonecrosis and Exhibit a Correlation between Affinity and Potency

(2012) C. Tkaczyk et al.   Clinical and Vaccine Immunology

The potential use of toxin antibodies as a strategy for controlling acuteStaphylococcus aureusinfections

(2012) Gordon YC Cheung et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Lower Antibody Levels to Staphylococcus aureus Exotoxins Are Associated With Sepsis in Hospitalized Adults With Invasive S. aureus Infections

(2012) R. P. Adhikari et al.   JOURNAL OF INFECTIOUS DISEASES

Staphylococcus aureus Leukotoxin GH Promotes Inflammation

(2012) Natalia Malachowa et al.   JOURNAL OF INFECTIOUS DISEASES

CCR5 is a receptor for Staphylococcus aureus leukotoxin ED

(2012) Francis Alonzo III et al.   NATURE

Novel Structurally Designed Vaccine for S. aureus α-Hemolysin: Protection against Bacteremia and Pneumonia

(2012) Rajan P. Adhikari et al.   PLoS One

Staphylococcus aureus Hemolysins, bi-component Leukocidins, and Cytolytic Peptides: A Redundant Arsenal of Membrane-Damaging Virulence Factors?

(2012) François Vandenesch et al.   Frontiers in Cellular and Infection Microbiology

Simulated Antibiotic Exposures in anIn VitroHollow-Fiber Infection Model Influence Toxin Gene Expression and Production in Community-Associated Methicillin-Resistant Staphylococcus aureus Strain MW2

(2011) Solen Pichereau et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A simple method of markerless gene deletion in Staphylococcus aureus

(2011) Fuminori Kato et al.   JOURNAL OF MICROBIOLOGICAL METHODS

Global Changes in Staphylococcus aureus Gene Expression in Human Blood

(2011) Natalia Malachowa et al.   PLoS One

Vancomycin Activates σB in Vancomycin-Resistant Staphylococcus aureus Resulting in the Enhancement of Cytotoxicity

(2011) Hong-Yi Chen et al.   PLoS One

Crystal structure of the octameric pore of staphylococcal  -hemolysin reveals the  -barrel pore formation mechanism by two components

(2011) K. Yamashita et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Secretion-and-capture cell-surface display for selection of target-binding proteins

(2011) J. A. Rakestraw et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Targeting of Alpha‐Hemolysin by Active or Passive Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model

(2010) Adam D. Kennedy et al.   JOURNAL OF INFECTIOUS DISEASES

Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury

(2010) B. A. Diep et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin

(2010) C. Garcia-Rodriguez et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Anti-Alpha-Hemolysin Monoclonal Antibodies Mediate Protection against Staphylococcus aureus Pneumonia

(2009) B. E. Ragle et al.   INFECTION AND IMMUNITY

Host Defense and Pathogenesis in Staphylococcus aureus Infections

(2009) Frank R. DeLeo et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Waves of resistance: Staphylococcus aureus in the antibiotic era

(2009) Henry F. Chambers et al.   NATURE REVIEWS MICROBIOLOGY

Vaccine protection againstStaphylococcus aureuspneumonia

(2008) Juliane Bubeck Wardenburg et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The Influence of Membrane Lipids in Staphylococcus aureus Gamma-Hemolysins Pore Formation

(2008) C. Potrich et al.   JOURNAL OF MEMBRANE BIOLOGY